CARSGEN-B_Providing professional financial news and data related to CARSGEN-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

CARSGEN-B(02171.HK): Kailimei® Secures NMPA Marketing Approval, the World’s First CAR-T Cell Therapy for Solid Tumors

Tags：

CARSGEN-B 02171.HK New Drug Application

2026-06-22

CARSGEN-B (02171.HK) plans to issue up to 23.7 million shares by placement, with estimated net proceeds of HKD 461.96 million

Tags：

CARSGEN-B 02171.HK Issue shares

2026-05-15

CARSGEN-B(02171.HK) closed 8.18% higher, The full-day turnover stood at HKD 190.55 million

Tags：

CARSGEN-B 02171.HK NewTimeSpace

2026-05-07

Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (June 22, 2026)
Finance
China Starch (03838.HK): Profit Warning, Expected Pre-Tax Loss of Approximately RMB 20 Million for Five-Month Period
Finance
Changjiu Co., Ltd. (06959.HK): Appoints Shi Yuan as Vice President and Chief Financial Officer
Finance
Kamsing Group (Holdings) (00794.HK): Profit Warning, Expected Annual Net Loss of Approximately HK$7.5 Million
Finance
Hengrui Medicine (01276.HK): Marketing Authorization Application for Relugolix Tablets Accepted by EMA
Finance
Regina Miracle International (02199.HK): Positive Profit Alert, Annual Net Profit Expected to Rise by No Less Than 45%
Finance
Dingli Capital (00356.HK): Completes Placing of Approximately 286 Million New Shares, Raising Around HK$13.99 Million
Finance
Shandong Xinhua Pharmaceutical Company Limited (00719.HK): LXH-2103 Injection Approved for Clinical Trials
Finance
Asiatic Group Holdings Proposes to Sell 49% Stake in Cambodian Joint Venture for US$3.1 Million
Finance
F J Benjamin Holdings Proposes Placing 42 Million New Ordinary Shares to Raise Approximately S$302,400

Scan QR Code

Download App